Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-08 · accession 0000950170-25-037574 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-11 | 2025-03-08+ | TMCI | Treace John T. | CEO, Dir, 10% | F - Tax | $0.00 | -7,084 | 6.79M | -0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-10 | F | D | 5,021 | $0.00 | 6,789,106 | D | — | — | (F2) Includes 408,448 restricted stock units |
| 2 | Common | Common Stock | 2025-03-08 | F | D | 2,063 | $0.00 | 6,794,127 | D | — | — | (F1) Includes 429,067 restricted stock units |